Primary |
Hypertension |
75.5% |
Diabetes Mellitus |
5.7% |
Blood Pressure |
2.8% |
Cardiac Disorder |
2.2% |
Angina Pectoris |
1.2% |
Depression |
1.1% |
Blood Pressure Abnormal |
1.0% |
Cardiac Failure |
1.0% |
Gastritis |
0.9% |
Insomnia |
0.9% |
Cerebral Infarction |
0.9% |
Hypercholesterolaemia |
0.8% |
Pain |
0.8% |
Blood Cholesterol |
0.8% |
Arrhythmia |
0.8% |
Atrial Fibrillation |
0.7% |
Hyperlipidaemia |
0.7% |
Gastric Ulcer |
0.7% |
Osteoporosis |
0.7% |
Anticoagulant Therapy |
0.6% |
|
Death |
21.8% |
Hypertension |
7.3% |
Cerebrovascular Accident |
6.7% |
Myocardial Infarction |
5.8% |
Diabetes Mellitus |
5.6% |
Pneumonia |
5.4% |
Blood Pressure Increased |
4.6% |
Wrong Technique In Drug Usage Process |
4.6% |
Vomiting |
4.1% |
Surgery |
3.9% |
Hypotension |
3.6% |
Infarction |
3.6% |
Malaise |
3.2% |
Syncope |
2.9% |
Weight Decreased |
2.9% |
Renal Failure |
2.9% |
Interstitial Lung Disease |
2.8% |
Tachycardia |
2.8% |
Oedema Peripheral |
2.7% |
White Blood Cell Count Increased |
2.7% |
|
Secondary |
Hypertension |
61.8% |
Diabetes Mellitus |
7.0% |
Product Used For Unknown Indication |
6.8% |
Drug Use For Unknown Indication |
4.1% |
Blood Pressure |
2.2% |
Pain |
2.1% |
Depression |
1.6% |
Cardiac Disorder |
1.5% |
Insomnia |
1.4% |
Arrhythmia |
1.2% |
Hyperlipidaemia |
1.2% |
Cardiac Failure |
1.2% |
Hyperuricaemia |
1.1% |
Blood Cholesterol Increased |
1.1% |
Blood Pressure Abnormal |
1.1% |
Hypercholesterolaemia |
1.0% |
Anxiety |
1.0% |
Acute Myocardial Infarction |
0.9% |
Atrial Fibrillation |
0.9% |
Hypothyroidism |
0.9% |
|
Wrong Technique In Drug Usage Process |
10.3% |
Hypertension |
8.3% |
Vomiting |
8.0% |
Death |
6.1% |
Weight Decreased |
5.7% |
Hypotension |
4.9% |
Weight Increased |
4.9% |
Blood Pressure Increased |
4.7% |
Malaise |
4.7% |
Urinary Tract Infection |
4.7% |
Renal Impairment |
4.6% |
Syncope |
4.1% |
Tachycardia |
4.0% |
White Blood Cell Count Increased |
3.8% |
Pneumonia |
3.8% |
Surgery |
3.8% |
Renal Failure Acute |
3.6% |
Dizziness |
3.4% |
Loss Of Consciousness |
3.4% |
Vision Blurred |
3.3% |
|
Concomitant |
Product Used For Unknown Indication |
25.9% |
Hypertension |
19.9% |
Drug Use For Unknown Indication |
13.4% |
Diabetes Mellitus |
5.0% |
Rheumatoid Arthritis |
4.7% |
Blood Cholesterol Increased |
2.9% |
Prophylaxis |
2.8% |
Depression |
2.7% |
Pain |
2.6% |
Type 2 Diabetes Mellitus |
2.5% |
Osteoporosis |
2.4% |
Atrial Fibrillation |
2.2% |
Gastrooesophageal Reflux Disease |
1.9% |
Blood Pressure |
1.8% |
Chronic Obstructive Pulmonary Disease |
1.8% |
Asthma |
1.6% |
Anxiety |
1.5% |
Hepatitis C |
1.5% |
Insomnia |
1.4% |
Cardiac Disorder |
1.4% |
|
Weight Decreased |
11.3% |
Vomiting |
11.2% |
Weight Increased |
7.4% |
Myocardial Infarction |
6.3% |
Drug Ineffective |
5.5% |
Nausea |
5.1% |
Flushing |
4.7% |
Urinary Tract Infection |
4.6% |
Pain |
4.3% |
Pruritus |
4.3% |
Rash |
4.3% |
Pain In Extremity |
3.9% |
Pyrexia |
3.6% |
Dyspnoea |
3.4% |
Pneumonia |
3.4% |
Vision Blurred |
3.4% |
Death |
3.4% |
Tremor |
3.4% |
White Blood Cell Count Decreased |
3.3% |
Oedema Peripheral |
3.1% |
|
Interacting |
Hypertension |
34.2% |
Product Used For Unknown Indication |
17.4% |
Pain |
10.7% |
Drug Use For Unknown Indication |
6.7% |
Gout |
3.4% |
Type 2 Diabetes Mellitus |
3.4% |
Arthritis |
2.0% |
Atrial Fibrillation |
2.0% |
Blood Pressure |
2.0% |
Blood Pressure Abnormal |
2.0% |
Cardiac Failure |
2.0% |
Dyspnoea |
2.0% |
Multiple Myeloma |
2.0% |
Pulmonary Hypertension |
2.0% |
Anticoagulant Therapy |
1.3% |
Cardiac Disorder |
1.3% |
Constipation |
1.3% |
Hyperlipidaemia |
1.3% |
Oropharyngeal Pain |
1.3% |
Osteoporosis Prophylaxis |
1.3% |
|
Surgery |
17.8% |
Hypertension |
8.9% |
Loss Of Consciousness |
8.9% |
Renal Failure |
8.9% |
Hyponatraemia |
6.7% |
Neck Pain |
6.7% |
Rhinorrhoea |
6.7% |
Abasia |
4.4% |
Dehydration |
4.4% |
Pyrexia |
4.4% |
Abdominal Pain Upper |
2.2% |
Blood Creatine Increased |
2.2% |
Dizziness |
2.2% |
Drug Interaction |
2.2% |
Flatulence |
2.2% |
Headache |
2.2% |
Heart Rate Irregular |
2.2% |
Lactic Acidosis |
2.2% |
Middle Insomnia |
2.2% |
Nutritional Condition Abnormal |
2.2% |
|